JBT-3002

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameJBT-3002
Drug Alias NameL-3002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase stimulantsImmunostimulants
TargetsNitric oxide synthase
Therapy Area/IndicationsNeoplasms +[2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJenner Biotherapies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJenner Biotherapies
Active IndicationsN/A
Inactive IndicationsNeoplasms +[2

Other Information

ATC CodeN/A
Related LinksN/A